Health Care & Life Sciences » Biotechnology | Proteome Sciences PLC

Proteome Sciences PLC | Ownership

Companies that own Proteome Sciences PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vulpes Investment Management Pte Ltd.
58,729,297
19.89%
3,511,866
1.79%
09/06/2018
ISPartners Investment Solutions AG
19,212,273
6.51%
4,000,000
2.48%
03/27/2017
Lombard Odier Asset Management (Europe) Ltd.
14,725,249
4.99%
0
0.02%
04/27/2017
Henderson Global Investors Ltd.
14,686,809
4.98%
-5,313,191
0%
03/31/2017
Hargreaves Lansdown Stockbrokers Ltd.
8,480,000
2.87%
162,000
0%
06/04/2018
Walker Crips Stockbrokers Ltd.
7,269,000
2.46%
0
0.02%
06/04/2018
J. M. Finn & Co. Ltd.
7,229,000
2.45%
-46,000
0.01%
06/04/2018
Hargreaves Lansdown Asset Management Ltd.
4,874,000
1.65%
-106,000
0%
06/04/2018
Alliance Trust Savings Ltd. (Private Banking)
4,816,000
1.63%
558,000
0%
06/04/2018
CA Indosuez (Switzerland) SA
3,600,000
1.22%
0
0.02%
06/04/2018

About Proteome Sciences

View Profile
Address
Hamilton House
London Greater London WC1H 9BB
United Kingdom
Employees -
Website http://proteomics.com
Updated 07/08/2019
Proteome Sciences Plc is engaged in applied proteomics and peptidomics services and applications. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection.